Drug firms Lupin Ltd and Aurobindo Pharma today said they have received US health regulator's approval to sell generic Combivir tablets, used in treating HIV infection, in the American market.
Drug maker Lupin Ltd today said its consolidated net profit declined by 29. 54 per cent to Rs 161
Drug firm Lupin today said it has received approval from the US health regulator for its generic Ziprasidone Hydrochloride capsules, used for treating mental disorders in the American market.
The
Drug maker Lupin today said it has reached a patent litigation settlement agreement with US-based firms Santarus Inc and Depomed Inc involving diabetes drug Glumetza.
The development, which could help
Pharma firm Lupin is ready with its pipeline of drug discoveries that would define its expansion plans. The discoveries include eight molecules across oncology and inflammation segments that are
Drug firm Lupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in treating diabetes.
The company's US-based subsidiary Lupin
Lupin Q3 up 5% at `235 cr
Drug firm Lupin today said its consolidated net profit rose by 4. 95 per cent to Rs 235
Stay informed on our latest news!
